Business Description
Walgreens Boots Alliance Inc
NAICS : 446110
SIC : 5912
ISIN : US9314271084
Share Class Description:
WBA: Ordinary SharesCompare
Compare
Traded in other countries / regions
WBA.USA0LSZ.UKWBA.MexicoW8A.GermanyWGBA34.Brazil1WBA.ItalyWBA.Austria IPO Date
1985-07-01Description
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | 0.16 | |||||
| Debt-to-Equity | 2.4 | |||||
| Debt-to-EBITDA | -3.07 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.62 | |||||
| Beneish M-Score | -2.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.2 | |||||
| 3-Year EPS without NRI Growth Rate | -2.4 | |||||
| 3-Year FCF Growth Rate | -67.3 | |||||
| 3-Year Book Growth Rate | -0.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -22.88 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.01 | |||||
| 9-Day RSI | 40.76 | |||||
| 14-Day RSI | 37.25 | |||||
| 6-1 Month Momentum % | -47.22 | |||||
| 12-1 Month Momentum % | -50.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.65 | |||||
| Quick Ratio | 0.31 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 26.43 | |||||
| Days Sales Outstanding | 14.72 | |||||
| Days Payable | 39.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 13.48 | |||||
| Dividend Payout Ratio | 0.46 | |||||
| 3-Year Dividend Growth Rate | 1.4 | |||||
| Forward Dividend Yield % | 10.97 | |||||
| 5-Year Yield-on-Cost % | 15.84 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 51.33 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.38 | |||||
| Operating Margin % | -0.97 | |||||
| Net Margin % | -3.99 | |||||
| FCF Margin % | -0.61 | |||||
| ROE % | -33.13 | |||||
| ROA % | -6.31 | |||||
| ROIC % | -1.64 | |||||
| 3-Year ROIIC % | -112.06 | |||||
| ROC (Joel Greenblatt) % | -40.36 | |||||
| ROCE % | -19.63 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 4.93 | |||||
| PE Ratio without NRI | 2.89 | |||||
| Shiller PE Ratio | 3.52 | |||||
| PS Ratio | 0.05 | |||||
| PB Ratio | 0.58 | |||||
| Price-to-Operating-Cash-Flow | 10.89 | |||||
| EV-to-EBIT | -3.04 | |||||
| EV-to-Forward-EBIT | 29.01 | |||||
| EV-to-EBITDA | -3.73 | |||||
| EV-to-Forward-EBITDA | 11.16 | |||||
| EV-to-Revenue | 0.27 | |||||
| EV-to-Forward-Revenue | 0.27 | |||||
| EV-to-FCF | -44.46 | |||||
| Price-to-Projected-FCF | 0.21 | |||||
| Price-to-Median-PS-Value | 0.14 | |||||
| Earnings Yield (Greenblatt) % | -32.89 | |||||
| FCF Yield % | -11.36 | |||||
| Forward Rate of Return (Yacktman) % | 47.81 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers